ACN vs DOX: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of August 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: DOX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACN and DOX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACN and DOX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. The company operates across five major service areas: Strategy and Consulting, Technology Services, Operations, Industry X (engineering and manufacturing digitization), and Song (marketing and customer experience). It earns revenue through a mix of consulting engagements, managed services contracts, and increasingly fixed-price, outcome-based arrangements, with managed services growing faster at roughly 10% year over year as of Q2 FY2026. The company serves clients in virtually every major industry vertical, from financial services and health to communications and government, and generates the majority of its revenue outside North America.

Full ACN guide

Amdocs Limited builds and operates the software that communications and media companies use to sell, bill and support their services. Its products sit in what the industry calls BSS and OSS: customer care, product catalogs, charging and billing, and order management on the commercial side, plus network orchestration, provisioning and service assurance on the operations side. Most of the revenue no longer comes from selling licenses. It comes from managed services, where Amdocs staff run those systems inside the carrier's own environment under multi-year contracts, a line that reached a record $791 million, or 67% of sales, in the June 2026 quarter. The rest is systems integration and cloud migration, the slow work of lifting decades-old on-premise stacks onto AWS, Azure and Google Cloud. Customers include AT&T, T-Mobile US, Vodafone, Telefonica's Vivo, Comcast, Lumen, Sunrise and Liberty Latin America. The company was founded in Israel in 1982, is incorporated in Guernsey, runs its main operating centers in Ra'anana and in Chesterfield, Missouri, employs roughly 30,000 people, and closes its fiscal year on September 30.

Full DOX guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• ACN drivers: Enterprise AI implementation at scale; Shift to recurring, outcome-based revenue.
• DOX drivers: Managed services turned a project vendor into an annuity; Cash return is carrying the load the growth rate is not.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. For DOX, customer concentration is the structural risk: AT&T has accounted for roughly a quarter of revenue in recent years and T-Mobile US is the next largest, so one carrier's budget decision moves the whole income statement, and management has already said it expects T-Mobile revenue to decline in fiscal 2026 as non-recurring work winds down.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACN if you believe its drivers more; DOX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACN and DOX guides.

ACN. Accenture's trailing P/E of roughly 10 to 13x represents a sharp discount to its own 5-year average of approximately 25x, a compression driven by AI cannibalization fears, federal spending headwinds, and a broader de-rating of large-cap professional services stocks rather than by any deterioration in underlying earnings, which have continued to grow. Operating margins near 17% and projected free cash flow of $10.8 billion to $11.5 billion in FY2026 reflect a business that is fundamentally sound and continuing to expand profitability. The elevated dividend yield above 3.5% (elevated because the share price has fallen roughly 38 to 40% over the prior 12 months) is now higher than Accenture's long-run average and is well covered by both earnings (roughly 52% payout ratio) and cash flows.

DOX. At about $57 a share, DOX trades near 13.6 times trailing GAAP earnings and roughly 7 times consensus non-GAAP earnings, a multiple usually reserved for businesses the market expects to shrink. Much of the gap between those two figures is the $106 million restructuring charge taken in the June quarter, which weighed on GAAP results without changing the cash flow guidance. Whether the discount is deserved depends less on any single quarter's revenue than on whether the 12-month backlog keeps renewing at current margins.

Headline figures (approximate, 2026-06-27): ACN shows revenue (ttm) ~$72 billion, revenue (fy2025, ended aug 31 2025) ~$69.7 billion (+7% YoY), q3 fy2026 revenue ~$18.7 billion (+5.6% YoY), q3 fy2026 eps (diluted) ~$3.82 (vs $3.52 in Q3 FY2025); DOX shows revenue (ttm) ~$4.65 billion, revenue (q3 fy2026) ~$1.175 billion, up ~2.7% year over year, non-gaap diluted eps (q3 fy2026) ~$1.84, 12-month backlog ~$4.26 billion, up ~2.7% year over year.

ACN and DOX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACN and DOX exposure against your real portfolio. It is not an investment adviser.